GE HealthCare integrates ultrasound into Medtronic’s Stealth AXiS surgical system
MedTech Dive • April 13, 2026
|
Stryker to buy Amplitude Vascular Systems
MedTech Dive • April 13, 2026
|
The seal strength paradox: Why more is not always better in sterile barrier packaging
MedTech Dive • April 13, 2026
|
Stryker makes IVL play with agreement to acquire Amplitude Vascular Systems - MassDevice
MassDevice • April 13, 2026
|
VB Spine completes deal to buy AR spine tech from Augmedics - MassDevice
MassDevice • April 13, 2026
|
Microbot Medical announces full US launch of endovascular robot - MassDevice
MassDevice • April 13, 2026
|
Johnson & Johnson ups 2026 outlook on Q1 beats, MedTech sales rise 7.7% - MassDevice
MassDevice • April 14, 2026
|
Protaryx earns FDA nod for transseptal puncture device - MassDevice
MassDevice • April 14, 2026
|
Siemens Healthineers, Cook Medical unveil integrated MRI suite - MassDevice
MassDevice • April 13, 2026
|
Avanos Medical agrees to be acquired by private equity firm in $1.3B deal - MassDevice
MassDevice • April 14, 2026
|
Johnson & Johnson reports positive Varipulse results at EHRA 2026 - MassDevice
MassDevice • April 13, 2026
|
Study backs Penumbra computer-assisted thrombectomy - MassDevice
MassDevice • April 13, 2026
|
Stryker makes a buy as Avalon to go private in a spate of medtech M&A deals
Fierce Biotech • April 14, 2026
|
Lilly makes preclinical ADC specialist CrossBridge its latest acquisition in vague $300M deal
Fierce Biotech • April 13, 2026
|
Alamar Biosciences files for IPO amid opening life sciences funding window
Fierce Biotech • April 14, 2026
|
FDA urges clinical trial sponsors to report the results of their studies
Fierce Biotech • April 13, 2026
|
Kailera outlines plans for $528.5M IPO to support quartet of Chinese obesity assets
Fierce Biotech • April 13, 2026
|
Spyre points to phase 2 win for ulcerative colitis drug as proof it could take on Takeda’s Entyvio
Fierce Biotech • April 13, 2026
|
AbbVie inks $745M deal with Chinese biotech Haisco for two acute pain assets
Fierce Biotech • April 13, 2026
|
Retractable Technologies trims staff to save $2.2M annually as tariffs bite
Fierce Biotech • April 13, 2026
|